<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0185-3325</journal-id>
<journal-title><![CDATA[Salud mental]]></journal-title>
<abbrev-journal-title><![CDATA[Salud Ment]]></abbrev-journal-title>
<issn>0185-3325</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0185-33252016000600303</article-id>
<article-id pub-id-type="doi">10.17711/SM.0185-3325.2016.035</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Adherencia a la medicación antipsicótica en pacientes indígenas con esquizofrenia]]></article-title>
<article-title xml:lang="en"><![CDATA[Adherence to antipsychotic medication in indigenous patients with schizophrenia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caqueo-Urízar]]></surname>
<given-names><![CDATA[Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Urzúa-M]]></surname>
<given-names><![CDATA[Alfonso]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Miranda-Castillo]]></surname>
<given-names><![CDATA[Claudia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Irarrázaval]]></surname>
<given-names><![CDATA[Matías]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Tarapacá Escuela de Psicología y Filosofía ]]></institution>
<addr-line><![CDATA[Arica ]]></addr-line>
<country>Chile</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Católica del Norte Escuela de Psicología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Chile</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Pontificia Universidad Católica de Chile Instituto de Sociología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Chile</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Chile Facultad de Medicina, Hospital Clínico Departamento de Psiquiatría]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Chile</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto Milenio para la Investigación en Depresión y Personalidad  ]]></institution>
<addr-line><![CDATA[Santiago ]]></addr-line>
<country>Chile</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>39</volume>
<numero>6</numero>
<fpage>303</fpage>
<lpage>310</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0185-33252016000600303&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0185-33252016000600303&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0185-33252016000600303&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción: La falta de adherencia a la medicación antipsicótica sigue siendo un problema en el tratamiento de pacientes con esquizofrenia, más aún en población indígena.  Objetivo: Evaluar las diferencias en la adherencia farmacológica, medida a través de la actitud hacia los antipsicóticos, entre pacientes aymara y no-aymara con esquizofrenia.  Método: La muestra estuvo compuesta por pacientes que recibían tratamiento en los Servicios Públicos de Salud Mental de Bolivia (32.8%), Perú (33.6%) y Chile (33.6%). Se utilizó el Inventario de Actitud hacia la Medicación (DAI-10); la Escala Barnes de Acatisia (EBA) como medida de efectos secundarios y la Escala para el Síndrome Positivo y Negativo de la Esquizofrenia (PANSS) para evaluar la severidad del trastorno.  Resultados: Los pacientes aymara presentan una menor adherencia que los pacientes no-aymara, sin embargo, estas diferencias no fueron significativas (t = 1.29; p = 0.19). La severidad del trastorno y la edad mostraron una asociación significativa con la adherencia, observándose que pacientes más jóvenes y con mayor sintomatología presentan una actitud más negativa hacia los fármacos.  Discusión y conclusión: Se discute cómo las dinámicas migratorias han promovido la pérdida de tradiciones y costumbres propias de la etnia promoviendo la adopción de estilos de vida nuevos y cada vez más interculturales, e incluso cambiando su concepción de la enfermedad mental. Los profesionales tratantes deben estar conscientes de no aplicar estereotipos en cuanto a la relación etnia-antipsicóticos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction: Non-adherence to antipsychotic medication remains a complex problem in the treatment of schizophrenia patients, especially in indigenous population.  Objective: The aim of the study was to assess the differences in drug adherence, measured by the attitude towards the antipsychotics among Aymara and Non-Aymara patients with schizophrenia.  Method: The sample consisted of patients receiving treatment in the Mental Health Public Services in Bolivia (32.8%), Peru (33.6%) and Chile (33.6%). We used the Drug Attitude Inventory (DAI-10); the Barnes Akathisia Scale (BAS), as a measure of side effects, and the Positive and Negative Syndrome Scale (PANSS) to assess the severity of the disorder.  Results: The findings showed that Aymara patients present less adherence than Non-Aymara people; however, these differences were not significant (t = 1.29; p = 0.19). The severity of the disorder, as well as the age, showed a significant association with adherence, revealing that younger patients and with greater symptoms presented a more negative attitude toward the drugs.  Discussion and conclusion: The lack of significant differences between the groups responds to three possible reasons: 1. This sample of indigenous patients is integrated on Mental Health Services that offer a clear biomedical approach where drug therapy is the primary treatment. 2. It is possible that these indigenous patients are changing their conception of mental disorder, and 3. A significant number of families have migrated to urban areas. These migratory dynamics have promoted the loss of traditions and customs of the ethnic group, which gradually adopts new and intercultural lifestyles. Professionals should be warned about applying stereotypes regarding the relationship between ethnicity and antipsychotics.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Indígenas]]></kwd>
<kwd lng="es"><![CDATA[esquizofrenia]]></kwd>
<kwd lng="es"><![CDATA[adherencia]]></kwd>
<kwd lng="es"><![CDATA[medicación]]></kwd>
<kwd lng="en"><![CDATA[Indigenous]]></kwd>
<kwd lng="en"><![CDATA[schizophrenia]]></kwd>
<kwd lng="en"><![CDATA[adherence]]></kwd>
<kwd lng="en"><![CDATA[medication]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited english proficiency]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gilmer]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Ojeda]]></surname>
<given-names><![CDATA[VD]]></given-names>
</name>
<name>
<surname><![CDATA[Barrio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fuentes]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Psych Serv]]></source>
<year>2009</year>
<volume>60</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>175-82</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Rebelliousness in patients suffering from schizophrenia-spectrum disorders - a possible predictor of adherence]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nitzan]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Bukobza]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aviram]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lev-Ran]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatr Res]]></source>
<year>2013</year>
<volume>209</volume>
<page-range>297-301</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Determinants of medication compliance in schizophrenia empirical and clinical findings]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fenton]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Blyler]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Heinssen]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Bull]]></source>
<year>1997</year>
<volume>23</volume>
<page-range>637-51</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jeste]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Palmer]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
<name>
<surname><![CDATA[Dolder]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Res]]></source>
<year>2003</year>
<volume>63</volume>
<page-range>49-58</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalence of and risk factors for medication nonadherence in patients with schizophrenia a comprehensive review of recent literature]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lacro]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Dolder]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Leckband]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2002</year>
<volume>63</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>892-909</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Compliance with treatment in schizophrenia a drug intervention program in a developing country]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Razali]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Yahya]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Acta Psychiatr Scand]]></source>
<year>1995</year>
<volume>91</volume>
<page-range>331-5</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[SX]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Christensen]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[AZ]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Med Res Opin]]></source>
<year>2007</year>
<volume>23</volume>
<page-range>2305-12</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The expert consensus guideline series adherence problems in patients with serious and persistent mental illness]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velligan]]></surname>
<given-names><![CDATA[DI]]></given-names>
</name>
<name>
<surname><![CDATA[Weiden]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sajatovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2009</year>
<volume>70</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>S1-S46</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Medication noncompliance in schizophrenia codification and update]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Zonana]]></surname>
<given-names><![CDATA[HV]]></given-names>
</name>
<name>
<surname><![CDATA[Shepler]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Bull Am Acad Psychiatry Law]]></source>
<year>1986</year>
<volume>14</volume>
<page-range>105-22</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical antipsychotic trials of intervention effectiveness (CATIE) investigators Effectiveness of antipsychotic drugs in patients with chronic schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lieberman]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Stroup]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[McEvoy]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Swartz]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2005</year>
<volume>353</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1209-23</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Adherence to long-term therapies evidence for action. World Health Organization]]></source>
<year>2003</year>
<page-range>107-14</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherencia y persistencia terapéutica causas, consecuencias y estrategias de mejora]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dilla]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Valladares]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lizán]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sacristán]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[Aten Primaria]]></source>
<year>2009</year>
<volume>41</volume>
<page-range>342-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment adhesion, treatment adherence or treatment compliance]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[López San Román]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Clin Esp]]></source>
<year>2006</year>
<volume>206</volume>
<page-range>414</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Salvà]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ampudia]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Maurino]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Patient Prefer Adherence]]></source>
<year>2012</year>
<volume>6</volume>
<page-range>623-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Factors influencing compliance in schizophrenia patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fleischhacker]]></surname>
<given-names><![CDATA[WW]]></given-names>
</name>
<name>
<surname><![CDATA[Oehl]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Hummer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2003</year>
<volume>64</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>10-3</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morken]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Widen]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Grawe]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
</person-group>
<source><![CDATA[BMC Psychiatry]]></source>
<year>2008</year>
<volume>8</volume>
<page-range>32-4</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Religious beliefs in schizophrenia Their relevance for adherence to treatment]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borras]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mohr]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[PY]]></given-names>
</name>
<name>
<surname><![CDATA[Gilliéron]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Bull]]></source>
<year>2007</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1238-46</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eaddy]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Grogg]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Locklear]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Ther]]></source>
<year>2005</year>
<volume>27</volume>
<page-range>263-72</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Woerner]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Alvir]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Gen Psychiatry]]></source>
<year>1999</year>
<volume>56</volume>
<page-range>241-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cost of relapse in schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weiden]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Olfson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Bull]]></source>
<year>1995</year>
<volume>21</volume>
<page-range>419-29</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment adherence in schizophrenia a patient-level meta-analysis of combined CATIE and EUFEST studies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Czobor]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Van Dorn]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Citrome]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Kahn]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur Neuropsychopharmacol]]></source>
<year>2015</year>
<volume>25</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1158-66</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Role of ethnicity in predicting antipsychotic medication adherence]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Opolka]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Rascati]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2003</year>
<month>a</month>
<volume>37</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>625-30</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Opolka]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Rascati]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Barner]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2003</year>
<month>b</month>
<volume>64</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>635-9</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of Ethnicity on Psychotropic Medications Adherence]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Woods]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenheck]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Community Ment Health J]]></source>
<year>2005</year>
<volume>41</volume>
<page-range>521-37</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gilmer]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Dolder]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Lacro]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Psychiatry]]></source>
<year>2004</year>
<volume>161</volume>
<page-range>692-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A psychosocial skills training approach in Mexican out-patients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rascon]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Juarez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Murow]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychol Med]]></source>
<year>2007</year>
<volume>37</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1393-402</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Application in Mexico of psychosocial rehabilitation with schizophrenia patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rascon]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Juarez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Escamilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatry]]></source>
<year>2010</year>
<volume>73</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>248-63</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Integrated treatment to achieve functional recovery for first-episode psychosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Juarez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Res Treatment]]></source>
<year>2012</year>
<volume>doi</volume>
<page-range>10</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fresan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Juárez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Escamilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[J Psychiatric Research]]></source>
<year>2013</year>
<volume>47</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1886-92</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Social-Skills training for Spanish-speaking persons with schizophrenia Experiences from Latin America, Spain, and the United States]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Moriana]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Kopelowicz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Psychiatr Rehabil]]></source>
<year>2015</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>209-46</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A self-report scale predictive of drug compliance in schizophrenics reliability and discriminative validity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hogan]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Awad]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Eastwood]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[J Psychol Med]]></source>
<year>1983</year>
<volume>13</volume>
<page-range>177-83</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A rating scale for drug-induced akathisia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Psychiatry]]></source>
<year>1989</year>
<volume>154</volume>
<page-range>672-6</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The positive and negative syndrome scale (PANSS) for schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kay]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Fiszbein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Opler]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Bull]]></source>
<year>1987</year>
<volume>13</volume>
<page-range>261-76</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Köster]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los Aymaras:Características demográficas de un grupo étnico indígena antiguo en los Andes centrales]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Van den Berg]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Schiffers]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[La cosmovisión Aymara La Paz,]]></source>
<year>1992</year>
<publisher-loc><![CDATA[Bolivia ]]></publisher-loc>
<publisher-name><![CDATA[UCB/ Hisbol]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[La cosmovisión Aymara En: Hidalgo J, Schiappacasse F, Niemeyer F, Aldunate C, Mege P. (eds.). Etnografía: Sociedades indígenas contemporáneas y su ideología]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Kessel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Santiago, Chile: Editorial Andrés Bello;]]></source>
<year>1996</year>
<volume>pp</volume>
<page-range>169-87</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Las organizaciones étnicas y el discurso de la identidad en el norte de Chile, 1980-2000]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gundermann]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudios Atacameños]]></source>
<year>2000</year>
<volume>19</volume>
<page-range>75-91</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Memoria e historia El proyecto de una identidad colectiva entre los aymaras de Chile]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zapata]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Chungara]]></source>
<year>2007</year>
<volume>39</volume>
<page-range>171-83</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tejiendo reciprocidades John Murra y el contextualizar entre los aymara contemporáneos en Chungara]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Munter]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Chungara]]></source>
<year>2010</year>
<volume>4</volume>
<page-range>243-51</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="">
<collab>Juntuma de Chapiquiña</collab>
<source><![CDATA[Medicina indígena y alimentación tradicional del pueblo de Chapiquiña. Trabajo fundando por el Programa de Salud y Pueblos Indígenas (PEPSI)]]></source>
<year>2002</year>
</nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laks]]></surname>
<given-names><![CDATA[Jordana]]></given-names>
</name>
</person-group>
<source><![CDATA[Reflexiones sobre la tristeza y la preocupación en las personas Aymara de Putre, Chile]]></source>
<year>2011</year>
<numero>Paper 1054</numero>
<issue>Paper 1054</issue>
</nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Ginebra,]]></source>
<year>1992</year>
<publisher-loc><![CDATA[Suiza ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[DAI-10 is as good as DAI-30 in schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Lindström]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Levander]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur Neuropsychopharmacol]]></source>
<year>2012</year>
<volume>22</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>747-50</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saleem]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hassali]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Shafie]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Awad]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<source><![CDATA[Trop J Pharm Res]]></source>
<year>2011</year>
<volume>10</volume>
<page-range>125-32</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluación de actitudes al medicamento en pacientes con esquizofrenia propiedades psicométricas de la versión en español del DAI]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez Barreto]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Robles García]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar Alvarado]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Páez Agraz]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Actas Esp Psiquiatr]]></source>
<year>2004</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>138-42</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Validación de la Escala de los Síndromes Positivo y Negativo (PANSS) en una muestra de esquizofrénicos españoles]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peralta]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cuesta]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Actas Luso Esp Neurol Psiquiatr Cienc Afines]]></source>
<year>1994</year>
<volume>22</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>171-7</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fresán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[De la Fuente-Sandoval]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Loyzaga]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[García-Anaya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Res]]></source>
<year>2005</year>
<volume>72</volume>
<page-range>123-9</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence to guidelines and treatment compliance in the Chilean national program for first-episode schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Markkula]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Minoletti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatr Serv]]></source>
<year>2011</year>
<volume>62</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1463-9</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Beliefs about the causes of schizophrenia among Aymara and non-Aymara patients and their primary caregivers in the Central-Southern Andes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caqueo-Urízar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Breslau]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gilman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Soc Psychiatry]]></source>
<year>2015</year>
<volume>61</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>82-91</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Acerca de cómo los aymaras aprendieron el castellano (terminando por olvidar el aymara)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gundermann]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudios Atacameños]]></source>
<year>1997</year>
<volume>12</volume>
<page-range>89-104</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gavilán]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Vigueras]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Carrasco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabezas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Pautas de crianza Aymara. Significaciones, actitudes y prácticas de familias Aymara en relación a la crianza y cuidado infantil de los niños y niñas desde la gestación hasta los diez]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Chile ]]></publisher-loc>
<publisher-name><![CDATA[Centro de Investigaciones para el Desarrollo del Hombre en el Desierto, Universidad Arturo Prat, Chile]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Social interaction and drug attitude effectiveness in patients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[WK]]></given-names>
</name>
<name>
<surname><![CDATA[Lung]]></surname>
<given-names><![CDATA[FW]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatr Q]]></source>
<year>2011</year>
<volume>82</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>343-51</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Symptom severity and attitudes toward medication Impacts on adherence in outpatients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ko]]></surname>
<given-names><![CDATA[Y-H]]></given-names>
</name>
<name>
<surname><![CDATA[Paik]]></surname>
<given-names><![CDATA[J-W]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophrenia Res]]></source>
<year>2012</year>
<volume>134</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>226-31</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Drug attitude as Predictor for effectiveness in first-episode schizophrenia results of an open randomized trial (EUFEST)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaebel]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Riesbeck]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[von]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur Neuropsychopharmacol]]></source>
<year>2010</year>
<volume>20</volume>
<page-range>310-6</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Crosssectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohamed]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenheck]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[McEvoy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Bull]]></source>
<year>2009</year>
<volume>35</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>336-46</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder an empirical evaluation of its reliability and predictive validity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nakonezny]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Byerly]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rush]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatry Res]]></source>
<year>2008</year>
<volume>157</volume>
<page-range>259-63</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The family and compliance in schizophrenia the influence of clinical variables, relatives' knowledge and expressed emotion]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sellwood]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Tarrier]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Quinn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychol Med]]></source>
<year>2003</year>
<volume>33</volume>
<page-range>91-6</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Attitudes of schizophrenia outpatients toward psychiatric medications relationship to clinical variables and insight]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freudenreich]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Cather]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Evins]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Henderson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2004</year>
<volume>65</volume>
<page-range>1372-6</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[How often do patients with psychosis fail to adhere to treatment programmes A systematic review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nosé]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Barbui]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tansella]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychol Med]]></source>
<year>2003</year>
<volume>33</volume>
<page-range>1149-60</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sajatovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Valenstein]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Blow]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ganoczy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatr Serv]]></source>
<year>2007</year>
<volume>58</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>855-63</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perkins]]></surname>
<given-names><![CDATA[DO]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Hamer]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Zipursky]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<source><![CDATA[Schizophr Res]]></source>
<year>2006</year>
<volume>83</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53-63</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder a randomized, double-blind, flexible-dose, multicenter study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perkins]]></surname>
<given-names><![CDATA[DO]]></given-names>
</name>
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Weiden]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[McEvoy]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2008</year>
<volume>69</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>106-13</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vassileva]]></surname>
<given-names><![CDATA[IV]]></given-names>
</name>
<name>
<surname><![CDATA[Milanova]]></surname>
<given-names><![CDATA[VK]]></given-names>
</name>
</person-group>
<source><![CDATA[Folia Med]]></source>
<year>2012</year>
<volume>54</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>62-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
